Enhanced susceptibility to Con A-induced liver injury in mice transgenic for the intracellular isoform of human TNF receptor type 2

Journal of Leukocyte Biology

Volumn 84, Issue 1, 2008, Pages 162-169

  Bäumel, Monika ^a   Lechner, Anja ^a   Hehlgans, Thomas ^a   Männel, Daniela N ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cytotoxicity; Hepatitis; p75TNF receptor

Indexed keywords

CONCANAVALIN A; ISOPROTEIN; LIPOPOLYSACCHARIDE; PROTEIN ICP75TNFR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSFECTION; HEPATITIS; HUMAN; HUMAN CELL; LIVER INJURY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL DEATH; CELL LINE; CONCANAVALIN A; DISEASE SUSCEPTIBILITY; GALACTOSAMINE; HUMANS; INTRACELLULAR SPACE; LIPOPOLYSACCHARIDES; LIVER DISEASES; MICE; MICE, TRANSGENIC; NEUTRALIZATION TESTS; PROTEIN ISOFORMS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); MUS; MUS MUSCULUS;

EID: 46949097403     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1007713     Document Type: Article

References (48)

1. Hehlgans, T., Pfeffer, K. (2005) The intriguing biology of the tumor necrosis factor/tumor necrosis factor receptor superfamily: players, rules and the games. Immunology 115, 1-20.
2. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J., Cerretti, D. P. (1997) A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells. Nature 385, 729-733.
3. Tang, P., Hung, M-C., Klostergaard, J. (1996) Human pro-tumor necrosis factor is a homotrimer. Biochemistry 35, 8216-8225.
4. Brockhaus, M., Schoenfeld, H. J., Schlaeger, E. J., Hunziker, W., Lesslauer, W., Loetscher, H. M. (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87, 3127-3131.
5. Thoma, B., Grell, M., Pfizenmaier, K., Scheurich, P. (1990) Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J. Exp. Med. 172, 1019-1023.
6. Horiuchi, K., Kimura, T., Miyamoto, T., Takaishi, H., Okada, Y., Toyama, Y., Blobel, C. P. (2007) TNF-α-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J. Immunol. 179, 2686-2689.
7. Grell, M., Douni, E., Wajant, H., Löhden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., Scheurich, P. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83, 793-802.
8. Holtmann, M. H., Neurath, M. F. (2004) Differential TNF-signaling in chronic inflammatory disorders. Curr. Mol. Med. 4, 439-444.
9. Hadziselimovic, F., Emmons, L. R., Gallati, H. (1995) Soluble tumor necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease. Gut 37, 260-263.
10. Haas, E., Grell, M., Wajant, H., Scheurich, P. (1999) Continuous autotropic signaling by membrane-expressed tumor necrosis factor. J. Biol. Chem. 274, 18107-18112.
11. Douni, E., Kollias, G. (1998) A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin α, or the p55TNF-R. J. Exp. Med. 188, 1343-1352.
12. Holtmann, M. H., Douni, E., Schütz, M., Zeller, G., Mudter, J., Lehr, H. A., Gerspach, J., Scheurich, P., Galle, P. R., Kollias, G., Neurath, M. F. (2002) Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo. Eur. J. Immunol. 32, 3142-3151.
13. Küsters, S., Tiegs, G., Alexopoulou, L., Pasparakis, M., Douni, E., Künstle, G., Bluethmann, H., Wendel, A., Pfizenmaier, K., Kollias, G., Grell, M. (1997) In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 27, 2870-2875.
14. Seitz, C., Männel, D. N., Hehlgans, T. (1998) Isolation and functional characterization of the mouse p75 TNF receptor promoter. Genomics 48, 111-116.
15. Hauser, A., Hehlgans, T., Männel, D. N. (2007) Characterization of TNF receptor type 2 isoform in the mouse. Mol. Immunol. 44, 3563-3570.
16. Scherübl, C., Schneider-Brachert, W., Schütze, S., Hehlgans, T., Männel, D. N. (2005) Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2. J. Inflamm. (Lond.) 2, 7.
17. Galanos, C., Lüderitz, O., Westphal, O. (1979) Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal). Zentralbl. Bakteriol. [Orig. A] 243, 226-244.
18. Schorpp, M., Jäger, R., Schellander, K., Schenkel, J., Wagner, E. F., Weiher, H., Angel, P. (1996) The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res. 24, 1787-1788.
19. Galanos, C., Freudenberg, M. A., Reutter, W. (1979) Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76, 5939-5943.
20. Tiegs, G., Hentschel, J., Wendel, A. (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196-203.
21. Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K. C., Schreiber, R. D., Goeddel, D. V., Moore, M. W. (1994) Decreased sensitivity to tumor-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372, 560-563.
22. Lucas, R., Juillard, P., Decoster, E., Redard, M., Burger, D., Donati, Y., Giroud, C., Monso-Hinard, C., De Kesel, T., Buurman, W. A., Moore, M. W., Dayer, J. M., Fiers, W., Bluethmann, H., Grau, G. E. (1997) Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27, 1719-1725.
23. Ebach, D. R., Riehl, T. E., Stenson, W. F. (2005) Opposing effects of tumor necrosis factor receptor 1 and 2 in sepsis due to cecal ligation and puncture. Shock 23, 311-318.
24. Vielhauer, V., Stavrakis, G., Mayadas, T. N. (2005) Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J. Clin. Invest. 115, 1199-1209.
25. Wajant, H., Pfitzenmaier, K., Scheurich, P. (2003) Tumor necrosis factor signaling. Cell Death Differ. 10, 45-65.
26. Chan, F. K., Shisler, J., Bixby, J. G., Felices, M., Zheng, L., Appel, M., Orenstein, J., Moss, B., Lenardo, M. J. (2003) A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 278, 51613-51621.
27. MacEwan, D. J. (2002) TNF ligands and receptors - a matter of life and death. Br. J. Pharmacol. 135, 855-875.
28. MacEwan, D. J. (2002) TNF receptor subtype signaling: differences and cellular consequences. Cell. Signal. 14, 477-492.
29. Fontaine, V., Mohand-Said, S., Hanoteau, N., Fuchs, C., Pfitzenmaier, K., Eisel, U. (2002) Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposing roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22, RC216.
30. Wilson, M. R., Goddard, M. E., O'Dea, K. P., Choudhury, S., Takata, M. (2007) Differential roles of p55 and p75 tumor necrosis factor receptors on stretch-induced pulmonary edema in mice. Am. J. Physiol. Cell. Mol. Physiol. 293, L60-L68.
31. Echtenacher, B., Männel, D. N. (2002) Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis. J. Endotoxin Res. 8, 365-369.
32. Sterns, T., Pollak, N., Echtenacher, B., Männel, D. N. (2005) Divergence of protection induced by bacterial products and sepsis-induced immune suppression. Infect. Immun. 73, 4905-4912.
33. Kim, E. Y., Teh, H. S. (2004) Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28. J. Immunol. 173, 4500-4509.
34. Chen, X., Bäumel, M., Männel, D. N., Howard, O. M., Oppenheim, J. J. (2007) Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179, 154-161.
35. Rothe, M., Sarma, V., Dixit, V. M., Goeddel, D. V. (1995) TRAF2-mediated activation of NFκB by TNF receptor 2 and CD40. Science 269, 1424-1427.
36. Cheng, G., Baltimore, D. (1996) TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-κB activation. Genes Dev. 10, 963-973.
37. Lee, S. Y., Lee, S. Y., Kandala, G., Liou, M. L., Liou, H. C., Choi, Y. (1996) CD30/TNF receptor-associated factor interaction: NF-κ B activation and binding specificity. Proc. Natl. Acad. Sci. USA 93, 9699-9703.
38. Hauer, J., Püschner, S., Ramakrishnan, P., Simon, U., Bongers, M., Federle, C., Engelmann, H. (2005) TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs. Proc. Natl. Acad. Sci. USA 102, 2874-2879.
39. Henkler, F., Baumann, B., Fotin-Mleczek, M., Weingärtner, M., Schwenzer, R., Peters, N., Graness, A., Wirth, T., Scheurich, P., Schmid, J. A., Wajant, H. (2003) Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-κB activation. J. Biol. Chem. 278, 29216-29230.
40. Munroe, M. E., Bishop, G. A. (2004) Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation. J. Biol. Chem. 279, 53222-53231.
41. Wang, C. Y., Mayo, M., Korneluk, R. G., Goeddel, D. V., Baldwin, A. S. (1998) NF-κB anti-apoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
42. Zhao, Y., Conze, D. B., Hanover, J. A., Ashwell, J. D. (2007) Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling. J. Biol. Chem. 282, 7777-7782.
43. Singer, S. S., Männel, D. N., Hehlgans, T., Brosius, J., Schmitz, J. (2004) From "junk" to gene: curriculum vitae of a primate receptor isoform gene. J. Mol. Biol. 341, 883-886.
44. Leist, M., Gantner, F., Jilg, S., Wendel, A. (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154, 1307-1316.
45. Solorzano, C. C., Ksontini, R., Pruitt, J. H., Hess, P. J., Edwards, P. D., Kaibara, A., Abouhamze, A., Auffenberg, T., Galardy, R. E., Vauthey, J. N., Copeland, E. M., Edwards, C. K., Lauwers, G. Y., Clare-Salzler, M., MacKay, S. L., Moldawer, L. L., Lazarus, D. D. (1997) Involvement of 26-kDa cell-associated TNF-α in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J. Immunol. 158, 414-419.
46. Chan, F. K., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., Lenardo, M. J. (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351-2354.
47. Rao, P., Hsu, K. C., Chao, M. V. (1995) Upregulation of NFκB dependent gene expression mediated by the p75 tumor necrosis factor receptor. J. Interferon Cytokine Res. 15, 171-177.
48. Boldin, M. P., Mett, I. L., Varfolomeev, E. E., Chumakov, I., Shemer-Avni, Y., Camonis, J. H., Wallach, D. (1995) Self association of the "death domains" of p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270, 387-391.